| Literature DB >> 29564091 |
Aloui Khouloud1,2, Salma Abedelmalek3, Hamdi Chtourou1, Nizar Souissi1.
Abstract
The aim of the study was to investigate the effect of a flavonoid-rich fresh fruit juice on cardiovascular, oxidative stress, and biochemical parameters during the yo-yo intermittent recovery test (YYIRT). Twenty-two healthy males subjects participated in this study divided into two groups: An experimental group (EG: n = 11) who consumed the antioxidant supplement and a control group (CG: n = 11). All participants performed two test sessions at 07:00 hr before and after 2 weeks of supplementation with Opuntia ficus-indica juice. Blood samples were taken before (P1) and immediately (P2) after the YYIRT. Our results showed that following the 2,2-diphenyl-1- picrylhydrazyl (DPPH ●) test, the Opuntia ficus-indica juice has an antioxidant capacity for capturing free radicals (p < .05) and reducing oxidative stress related to exercise. Concerning biochemical and cardiovascular parameters, our results showed a significant increase on total cholesterol (TC) (p < .01), triglycerides (TG) (p < .05), high-density lipoprotein (HDL) (p < .01), low-density lipoprotein (LDL) (p < .01), creatine kinase (CK) (p < .01), lactate deshydrogenase (LDH) (p < .01), glucose (GLC) (p < .01), systolic (SBP), and diastolic blood pressure (DBP) (p < .01) immediately after exercise. However, TC (p < .05), TG (p < .05) and LDL (p < .05), the maximal heart rate (HRmax), the CK (p < .05), and LDH (p < .01) as well as the malondialdehyde (MDA) (p < .01) demonstrated a significant decrease after supplementation of Opuntia ficus-indica juice before and immediately after YYIRT. However, no significant effect on HDL (p > .05), GLC (p > .05) levels nor the SBP and DBP (p > .05) was observed after supplementation with Opuntia ficus-indica juice. The supplementation leads to an improvement on YYIRT performance (The total distance covered during the YYIRT,VO 2max, VMA) and the rating of perceived exertion (RPE). Opuntia ficus-indica juice has a potent antioxidant activity that reduces total and LDL-cholesterol with only a moderate lowering of HDL-cholesterol and oxidative stress. Moreover, supplementation decreases muscle damage caused by the endurance exercise.Entities:
Keywords: Supplementation; biochemical response; cardiovascular response; exercise; oxidative stress
Year: 2017 PMID: 29564091 PMCID: PMC5849923 DOI: 10.1002/fsn3.529
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
(Mean ± SE) values for daily nutrition consumption and anthropometric parameters in both group
| CG ( | EG ( |
| |
|---|---|---|---|
| Age (years) | 20.91 ± 1.22 | 21.00 ± 0.84 | NS; |
| Height (cm) | 181.82 ± 8.13 | 181.36 ± 2.28 | NS; |
| Weight (kg) | 73.10 ± 1.90 | 72.75 ± 1.79 | NS; |
| BMI (kg/m2) | 22.13 ± 0.49 | 22.15 ± 0.54 | NS; |
| Energy intake (Kcal/day) | 3084.9 ± 74.1 | 2905.3 ± 69 | NS; |
| Protein (g/day) | 107.7 ± 4.9 | 104.3 ± 4.8 | NS; |
| Fat (g/day) | 89.5 ± 1.9 | 84.6 ± 2.1 | NS; |
| Carbohydrate (g/day) | 451.3 ± 12.07 | 420.1 ± 9.7 | NS; |
| Vitamin E (g/day) | 12 ± 0.3 | 12.2 ± 0.4 | NS; |
| Vitamin C (g/day) | 52.9 ± 0.2 | 51.3 ± 0.9 | NS; |
Figure 1Experimental protocol
Figure 2Antioxidant effect depending on the volume of the extract of Opuntia ficusindica and ethanol
Values (mean ± SE) of YYIRT parameters and RPE before and after supplementation
| EG | CG | |||
|---|---|---|---|---|
| Before supplementation | After supplementation | Before supplementation | After supplementation | |
|
| 48.07 ± 0.57 | 49.67 ± 0.54 | 47.42 ± 0.62 | 47.73 ± 0.76 |
| VMA (km.h−1) | 14.11 ± 0.26 | 14.70 ± 0.20 | 13.87 ± 0.23 | 13.99 ± 0.25 |
| Distance (m) | 978.18 ± 97.74 | 1200.00 ± 74.543 | 887.27 ± 85.59 | 930.91 ± 93.74 |
| RPE | 16.18 ± 0.52 | 14.55 ± 0.44 | 16.82 ± 0.30 | 16.18 ± 0.23 |
VMA, Maximal aerobic speed; RPE, Rate of perceived exertion; EG, Experimental group; CG, Control group; YYIRT, Yo‐Yo intermittent recovery test.
Significant difference compared with before supplementation (p < .05).
Significant difference after supplementation for EG versus CG (p < .05).
Cardiovascular parameters (mean ± SE) measured Before (P1) and After (P2) the YYIRT, before and after supplementation
| EG | CG | |||||||
|---|---|---|---|---|---|---|---|---|
| Before supplementation | After supplementation | Before supplementation | After supplementation | |||||
| P1 | P2 | P1 | P2 | P1 | P2 | P1 | P2 | |
| DBP (mmHg) | 81.91 ± 2.64 | 97.73 ± 2.53 | 82.00 ± 4.14 | 93.73 ± 2.50 | 81.45 ± 1.55 | 92.73 ± 1.51 | 84.18 ± 1.96 | 91.91 ± 1.82 |
| SBP (mmHg) | 133.82 ± 2.29 | 159.82 ± 2.54 | 131.09 ± 4.04 | 156.64 ± 1.61 | 133.91 ± 2.11 | 157.45 ± 1.71 | 134.55 ± 1.75 | 157.27 ± 2.27 |
| HRmax (bpm) | 192.81 ± 1 .33 | 188.90 ± 1.71 | 193.81 ± 1.57 | 192.54 ± 1.50 | ||||
DBP, diastolic blood pressure; SBP, systolic blood pressure; HRmax, maximal heart rate; EG, Experimental group; CG, Control group; YYIRT, Yo‐Yo intermittent recovery test.
Significant difference compared with supplementation (p < .05).
Significant difference following the YYIRT (p < .05).
Biochemical markers and MDA (mean ± SE) measured Before (P1) and After (P2) the YYIRT, before and after supplementation
| EG | CG | |||||||
|---|---|---|---|---|---|---|---|---|
| Before supplementation | After supplementation | Before supplementation | After supplementation | |||||
| P1 | P2 | P1 | P2 | P1 | P2 | P1 | P2 | |
| LDL‐ Cholesterol (mmol.l−1) | 0.96 ± 0.07 | 1.29 ± 0.05 | 0.58 ± 0.03 | 1.02 ± 0.03 | 0.89 ± 0.04 | 1.1 ± 0.06 | 0.88 ± 0.04 | 1.11 ± 0.05 |
| HDL‐ Cholesterol (mmol.l−1) | 0.76 ± 0.04 | 1.18 ± 0.07 | 0.77 ± 0.04 | 1.19 ± 0.07 | 0.77 ± 0.03 | 1.03 ± 0.02 | 0.89 ± 0.06 | 1.06 ± 0.06 |
| Total Cholesterol (mmol.l−1) | 2.93 ± 0.16 | 3.83 ± 0.15 | 2.53 ± 0.09 | 3.49 ± 0.17 | 2.52 ± 0.09 | 3.54 ± 0.13 | 2.51 ± 0.08 | 3.61 ± 0.12 |
| Triglycerides (mmol.l−1) | 0.89 ± 0.05 | 1.40 ± 0.12 | 0.78 ± 0.07 | 1.03 ± 0.05 | 0.78 ± 0.07 | 1.10 ± 0.05 | 0.82 ± 0.06 | 1.09 ± 0.05 |
| LDH (UI.l−1) | 264.54 ± 24.27 | 420.9 ± 28.6 | 232.36 ± 14.9 | 283.72 ± 16.58 | 269.9 ± 8.97 | 438.36 ± 25.2 | 271.9 ± 8.82 | 449.9 ± 21.3 |
| CK (UI.l−1) | 170.63 ± 16.01 | 268.18 ± 27.09 | 121.7 ± 5.9 | 184.63 ± 19.45 | 165.8 ± 2.56 | 241.09 ± 9.31 | 167.18 ± 2.27 | 242.27 ± 11.5 |
| GLC (mmol.l−1) | 4.88 ± 0.10 | 5.97 ± 0.09 | 4.63 ± 0.05 | 5.66 ± 0.13 | 4.37 ± 0.13 | 5.62 ± 0.11 | 4.38 ± 0.12 | 5.66 ± 0.11 |
| MDA (μmol/L) | 0.93 ± 0.02 | 1.02 ± 0.02 | 0.80 ± 0.02 | 0.87 ± 0.01 | 0.95 ± 0.03 | 1.02 ± 0 .05 | 0.9 ± 0.04 | 0.91 ± 0.03 |
LDL, low‐density lipoprotein; HDL, high density lipoprotein; LDH, lactate dehydrogenase; CK, creatine kinase; GLC, blood glucose; MDA, malondialdehyde; EG, Experimental group; CG, Control group; YYIRT, Yo‐Yo intermittent recovery test.
Significant difference following the YYIRT (p < .05).
Significant difference EG versus CG after supplementation (p < .05).